Fosrenol
These highlights do not include all the information needed to use FOSRENOL safely and effectively. See full prescribing information for FOSRENOL. FOSRENOL (lanthanum carbonate) chewable tablets, for oral use FOSRENOL (lanthanum carbonate) oral powder, for oral use Initial U.S. Approval: 2004
f10776b2-2c25-4343-aabe-68f302e5cb54
HUMAN PRESCRIPTION DRUG LABEL
Dec 20, 2023
Takeda Pharmaceuticals America, Inc.
DUNS: 039997266
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
lanthanum carbonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
lanthanum carbonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
lanthanum carbonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
lanthanum carbonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
lanthanum carbonate
Product Details
FDA regulatory identification and product classification information